Sima P. Porten

Also affiliated with University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of San Francisco, Icahn School of Medicine at Mount Sinai

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

14.6Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Papers

Driven by 29 papers — median percentile 98. Top paper: “An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics”.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer

Cell(2020)10.1016/j.cell.2020.05.017

N/A

5.5DataRank · unranked

749 citations

Serena S. Kwek, Siddharth S. Raju, Tony Li, Elizabeth McCarthy, Eric D. Chow +15 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605

European Urology(2023)10.1016/j.eururo.2023.08.004

N/A

2.9DataRank · unranked

93 citations

Catherine M. Tangen, Parminder Singh, David J. McConkey, M. Scott Lucia, William T. Lowrance +10 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates

JCO Precision Oncology(2024)10.1200/po.23.00362

N/A

0.262DataRank · unranked

3 citations

Henkel Valentine, David Liu, Michael J. Slifker, Costas D. Lallas, Edouard J. Trabulsi +24 more

Discovering dominant tumor immune archetypes in a pan-cancer census

Cell(2021)10.1016/j.cell.2021.12.004

N/A

0DataRank · unranked

176 citations

Bushra Samad, Jessica Tsui, Nayvin W. Chew, Peter Yan, Gabriella C. Reeder +75 more

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4175

N/A

0DataRank · unranked

156 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer

European Urology(2021)10.1016/j.eururo.2021.03.017

N/A

0DataRank · unranked

18 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Yang Liu, Jonathan Chou +17 more

Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4541

N/A

0DataRank · unranked

27 citations

Catherine M. Tangen, Parminder Singh, David J. McConkey, Scott Lucia, William T. Lowrance +10 more

Phase II trial of escalating doses of neoadjuvant atezolizumab for patients with non-metastatic urothelial carcinoma ineligible for cisplatin-based neoadjuvant chemotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.442

N/A

0DataRank · unranked

8 citations

Divya Natesan, Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng +6 more

Updated results of phase II trial using escalating doses of neoadjuvant atezolizumab for cisplatin-ineligible patients with nonmetastatic urothelial cancer (NCT02451423).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16510

N/A

0DataRank · unranked

5 citations

Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng, Raj S. Pruthi +15 more

TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells

European Urology Oncology(2022)10.1016/j.euo.2021.11.005

N/A

0DataRank · unranked

87 citations

Kai Trepka, Martin Sjöström, Emily A. Egusa, Carissa Chu, Jun Zhu +14 more

Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney Cancer

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0588

N/A

0DataRank · unranked

47 citations

Alexis J. Combes, Arjun A. Rao, Mikhail Binnewies, Bushra Samad, Jessica Tsui +10 more

Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non–muscle-invasive Bladder Cancer (BRIDGE)

European Urology Focus(2023)10.1016/j.euf.2023.06.006

N/A

0DataRank · unranked

49 citations

Xiangying Chu, Noah M. Hahn, Eugene J. Pietzak, Angela B. Smith, Daniel H. Shevrin +9 more

Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer

Bladder Cancer(2023)10.3233/blc-230056

N/A

0DataRank · unranked

8 citations

Noah M. Hahn, Seth P. Lerner, Jaleh Fallah, Sundeep Agrawal, Ashish M. Kamat +33 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730

N/A

0DataRank · unranked

0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730.v1

N/A

0DataRank · unranked

0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Data from Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney Cancer

(2023)10.1158/2326-6066.c.6550550

N/A

0DataRank · unranked

0 citations

Alexis J. Combes, Arjun A. Rao, Mikhail Binnewies, Bushra Samad, Jessica Tsui +10 more

Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer

European Urology(2025)10.1016/j.eururo.2025.03.023

N/A

0DataRank · unranked

15 citations

Parminder Singh, David J. McConkey, M. Scott Lucia, Vadim S. Koshkin, Kelly Stratton +16 more

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

Nature Communications(2025)10.1038/s41467-025-62710-0

N/A

0DataRank · unranked

8 citations

Henry M. Delavan, Elizabeth Yip, Corynn Kasap, Jun Zhu, Roshan Lodha +21 more

Identification and regulation of circulating tumor-TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancer

JCI Insight(2025)10.1172/jci.insight.177373

N/A

0DataRank · unranked

4 citations

Hai Yang, Tony Li, Arielle Ilano, Eric D. Chow, Li Zhang +13 more

Race modifies survival benefit of guideline‐based treatment: Implications for reducing disparities in muscle invasive bladder cancer

Cancer Medicine(2020)10.1002/cam4.3429

N/A

0DataRank · unranked

13 citations

Steven E. Gregorich, Maxwell V. Meng, Anne M. Suskind, Sima P. Porten, Samuel L. Washington

Assessing Contemporary Trends in Female Speakership within Urologic Oncology

Urology(2020)10.1016/j.urology.2020.08.006

N/A

0DataRank · unranked

15 citations

Adrien Bernstein, Amanda E. Jones, Juanita Crook, Andrea B. Apolo, Jennifer M. Taylor +7 more

Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy

Urology(2020)10.1016/j.urology.2020.11.036

N/A

0DataRank · unranked

11 citations

Lauren Law, Kyle B. Zuniga, Tracy Kuo Lin, Candy Tsourounis, Rosa Rodríguez-Monguió +10 more

Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5022

N/A

0DataRank · unranked

55 citations

Catherine M. Tangen, Parminder Singh, David J. McConkey, Scott Lucia, William T. Lowrance +11 more

Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.24

N/A

0DataRank · unranked

5 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +14 more

Characterization of PSMA and 18F-fluciclovine transporter gene expression in localized prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.295

N/A

0DataRank · unranked

0 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +15 more

Sima P. Porten

Indexed papers

Top data-sharing exemplar

Papers